Attention all users - Due to a recent spike in spam activities, we have increased our measures to flag spam content on OSF. Contact firstname.lastname@example.org if you believe your content has been flagged in error.
This projects has two aims. First, we examine whether the current evaluation process of the FDA leads to psychotropic drugs (i.e., antidepressants, antipsychotics, and ADHD medication) supported by substantial evidence (at the time of approval). Second, we determine whether there are systematic differences in strength of evidence, trial characteristics, and number of trials for psycho-active drugs across mental disorders and examine whether these potential differences are reflected in the associated evidence load.
A preprint can be found here : https://www.medrxiv.org/content/10.1101/2021.03.04.21252887v1
Get more citations
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information,
and information on cookie use.